Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Zoledronic Acid 8Letrozole 4Vitamin D 3Calcium 3Risedronic Acid 2Nutrition Assessment 2Denosumab 2Cholecalciferol 2Calcium Gluconate 2Calcium Carbonate 2Aromatase Inhibitors 2parathyroid hormone-related peptide (1-36) 1Technetium 1Resistance Training 1Radiotherapy 1Observation 1Kyphoplasty 1Ibandronic Acid 1Gonadotropin-Releasing Hormone 1Geritol 1Calcium Citrate 1Anastrozole 1Alendronate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Osteoporosis × Alendronate × Clear all
NCT02304757 2021-11-17

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
142 enrolled 7 charts

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡